Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About The Bank of New York Mellon Corporation (NYSE:BK)

Is The Bank of New York Mellon Corporation (NYSE:BK) ready to raly soon? The smart money is taking a bullish view. The number of bullish hedge fund positions improved by 2 in recent months.

The Bank of New York Mellon Corporation (NYSE:BK)

At the moment, there are a multitude of indicators investors can use to track publicly traded companies. A duo of the best are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top investment managers can outpace the broader indices by a healthy margin (see just how much).

Just as key, bullish insider trading sentiment is another way to break down the stock market universe. Obviously, there are a number of incentives for a corporate insider to downsize shares of his or her company, but only one, very obvious reason why they would buy. Many academic studies have demonstrated the impressive potential of this method if you understand where to look (learn more here).

With all of this in mind, we’re going to take a gander at the recent action encompassing The Bank of New York Mellon Corporation (NYSE:BK).

How are hedge funds trading The Bank of New York Mellon Corporation (NYSE:BK)?

In preparation for this year, a total of 36 of the hedge funds we track were long in this stock, a change of 6% from one quarter earlier. With the smart money’s sentiment swirling, there exists a few key hedge fund managers who were increasing their holdings significantly.

When looking at the hedgies we track, Mason Hawkins’s Southeastern Asset Management had the biggest position in The Bank of New York Mellon Corporation (NYSE:BK), worth close to $1.157 billion, comprising 5.1% of its total 13F portfolio. On Southeastern Asset Management’s heels is Jean-Marie Eveillard of First Eagle Investment Management, with a $627 million position; 0.3% of its 13F portfolio is allocated to the stock. Remaining hedge funds that are bullish include Warren Buffett’s Berkshire Hathaway, Martin Whitman’s Third Avenue Management and Donald Yacktman’s Yacktman Asset Management.

With a general bullishness amongst the heavyweights, some big names were leading the bulls’ herd. Ascend Capital, managed by Malcolm Fairbairn, initiated the most valuable position in The Bank of New York Mellon Corporation (NYSE:BK). Ascend Capital had 6 million invested in the company at the end of the quarter. Neil Chriss’s Hutchin Hill Capital also made a $3 million investment in the stock during the quarter. The other funds with new positions in the stock are Ray Dalio’s Bridgewater Associates, , and Paul Tudor Jones’s Tudor Investment Corp.

How are insiders trading The Bank of New York Mellon Corporation (NYSE:BK)?

Bullish insider trading is best served when the company in question has experienced transactions within the past six months. Over the latest half-year time period, The Bank of New York Mellon Corporation (NYSE:BK) has experienced zero unique insiders buying, and 9 insider sales (see the details of insider trades here).

With the results shown by the aforementioned time-tested strategies, retail investors should always monitor hedge fund and insider trading sentiment, and The Bank of New York Mellon Corporation (NYSE:BK) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!